Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOGIK1902: Weekly carboplatin with concurrent radiotherapy for locally advanced NSCLC in elderly patients
jRCTs071200019Phase 2Completed
- Start
- Sep 2020
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of carboplatin in non-small cell lung cancer (NSCLC). Primary endpoint: Response rate. Started Sep 2020; status: completed.
02
Drugs
carboplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on jRCTs071200019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071200019.